TC-83-derived alphavirus vectors, particles and methods

Details for Australian Patent Application No. 2005245956 (hide)

Owner Alphavax, Inc.

Inventors Hubby, Bolyn; Rayner, Jon O.; Reap, Elizabeth A.; Smith, Jonathan F.

Agent Wrays

Pub. Number AU-B-2005245956

PCT Pub. Number WO2005/113782

Priority 60/572,212 18.05.04 US

Filing date 18 May 2005

Wipo publication date 1 December 2005

Acceptance publication date 19 May 2011

International Classifications

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/113782 Priority application(s): WO2005/113782

19 May 2011 Application Accepted

  Published as AU-B-2005245956

15 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005245962-Bacterial efflux pump inhibitors and methods of treating bacterial infections

2005245950-Liquid formulations for coating and printing substrates